Cite this article
Volume | Year
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cantharidin is superior to trichloroacetic acid for the treatment of non-mucosal genital warts: a pilot randomized controlled trial
M.A. Recanati1, *, K.J. Kramer1, J.J. Maggio1, C.R. Chao1
1 Wayne State University, C.S. Mott Center for Human Growth and Development, Detroit MI, USA
Clin. Exp. Obstet. Gynecol. 2018, 45(3), 383–386; https://doi.org/10.12891/ceog4112.2018
Published: 10 June 2018
Condyloma acuminatum is a sexually transmitted viral disease caused by the human papillomavirus (HPV). It is the most common viral sexually transmitted disease. In this randomized controlled trial, cantharidin was found to be more effective and better tolerated than trichloro-acetic acid (TCA) for the treatment of these lesions. Patients treated with cantharidin healed with less scarring than those treated with TCA (p < 0.034), had less pain during treatment (p < 0.01), and required fewer treatments to eradicate warts (p < 0.01) when compared to trichloroacetic acid.